Genefluence’s rapid PCR test for UTIs is now in clinical use, enabling one-hour detection of pathogens and resistance genes.

Watchmaker Genomics launched a PCR-free whole genome sequencing workflow integrating library prep and normalization.

The enterprise digital pathology platform, powered by Tribun Health, integrates pathology, radiology, and cardiology imaging ...

Ozelle will present its AI-assisted hematology analyzer at MEDICA 2026, offering CBC, 7-part WBC differentials, and digital ...

FDA clears Sekisui Diagnostics’ rapid combo test for COVID-19 and flu A&B, offering CLIA-waived, 510(k)-cleared pathogen ...

Path Fertility secures $2 million NIH grant to develop and validate a semen-based epigenetic assay for NOA and cancer risk.

Agendia presented data on an AI pathology model that predicts breast cancer recurrence risk from routine biopsy slides.

Tempus xR RNA sequencing assay receives EU IVDR Class C certification, supporting continued clinical and biopharma access in ...

FDA grants bioMérieux dual clearance and CLIA waiver for the BIOFIRE SPOTFIRE Vaginitis Panel, a rapid 20-minute ...

Abbott’s WGS-based Oncodetect MRD test showed a 30% sensitivity improvement for post-surgical colorectal cancer recurrence.

Quest Diagnostics and Waters will expand at-home HPV screening in 2027, offering extended genotyping via the Onclarity ...

Hologic has agreed to acquire Reveal Genomics, adding the HER2DX assay to its breast cancer genomic testing portfolio, the ...